Kuhn & Co Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$974K Hold
2,768
0.63% 48
2025
Q4
$906K Buy
2,768
+18
+0.7% +$5.71K 0.6% 50
2025
Q3
$776K Sell
2,750
-18
-0.7% -$5.22K 0.61% 50
2025
Q2
$773K Hold
2,768
0.58% 58
2025
Q1
$862K Hold
2,768
0.73% 40
2024
Q4
$721K Hold
2,768
0.61% 52
2024
Q3
$892K Hold
2,768
0.76% 39
2024
Q2
$865K Hold
2,768
0.78% 40
2024
Q1
$787K Hold
2,768
0.74% 42
2023
Q4
$797K Buy
+2,768
New +$754K 0.82% 43

Other funds holding AMGN

Kuhn & Co Investment Counsel's AMGN Position: Q1 2026 in Review

Kuhn & Co Investment Counsel held its Amgen (AMGN) position steady in Q1 2026 at 2,768 shares worth $974K. The position accounts for 0.63% of the portfolio, ranked #48.

Kuhn & Co Investment Counsel first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Kuhn & Co Investment Counsel held 2,768 shares of Amgen worth $974K as of Q1 2026.
  • Kuhn & Co Investment Counsel left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.63% of Kuhn & Co Investment Counsel's portfolio in Q1 2026, its #48 holding.
  • Kuhn & Co Investment Counsel first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q1 2026, filed 12 May 2026.